Revenue Breakdown
Composition ()
No data
Revenue Streams
iRhythm Holdings, Inc (IRTC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Commercial Payors, accounting for 51.3% of total sales, equivalent to $99.01M. Other significant revenue streams include Contracted third-party payors and Centers for Medicare & Medicaid. Understanding this composition is critical for investors evaluating how IRTC navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, iRhythm Holdings, Inc maintains a gross margin of 71.09%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2.54%, while the net margin is -2.70%. These profitability ratios, combined with a Return on Equity (ROE) of -53.15%, provide a clear picture of how effectively IRTC converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, IRTC competes directly with industry leaders such as CELC and SHC. With a market capitalization of $5.00B, it holds a significant position in the sector. When comparing efficiency, IRTC's gross margin of 71.09% stands against CELC's N/A and SHC's 56.04%. Such benchmarking helps identify whether iRhythm Holdings, Inc is trading at a premium or discount relative to its financial performance.
